News Daily News Ross Procedure Offers ‘Excellent Survival’ 25 Years Out Caitlin E. Cox November 15, 2023
News Daily News SAVR 5-Year Survival Tops 92% in Low-Risk Patients: STS Registry Yael L. Maxwell October 20, 2023
News Daily News Stark Inequities Plague AVR Rates for Women, Minorities in England L.A. McKeown October 04, 2023
News Daily News US and European Valvular Guidelines Mostly Concordant, Analysis Finds L.A. McKeown August 21, 2023
News Daily News Abbott to Stop Making Trifecta Surgical Aortic Valves Michael O'Riordan July 31, 2023
News Daily News For Moderate AS Patients, Baseline Factors Can Help ID Who’s Most at Risk Caitlin E. Cox July 13, 2023
News Daily News TAVI Explantation Remains a Risky Proposition, Two New Studies Show Michael O'Riordan April 27, 2023
News Daily News FDA Alert: Possible Early Deterioration of Abbott Trifecta SAVR Valves Todd Neale February 27, 2023
News Daily News Adopting TEER Doesn’t Put a Dent in Surgical MV Repair Volumes Todd Neale February 07, 2023
News Daily News Patient Risk, Follow-up Duration Drive SAVR, TAVI Outcomes: Meta-analysis Todd Neale January 20, 2023
News Daily News No Benefit to More-Complete Coronary Revascularization Before TAVI, Registry Shows Todd Neale December 29, 2022
News Daily News Aortic Valve Disease Particularly Challenging to Manage Before Age 65: Review Todd Neale December 28, 2022
News Daily News Psychosocial Risk Affects AVR Recovery, Merits Heart Team Consideration L.A. McKeown November 24, 2022
News Daily News Surgical Societies Question VARC-3 Endpoints for Valve Disease Trials Michael O'Riordan March 23, 2022
News Daily News Subclinical Leaflet Thrombosis After TAVI Linked to Higher Mortality Michael O'Riordan March 10, 2022
News Daily News Good Results For TAVI in Bicuspid Valves, but Questions Persist Michael O'Riordan March 08, 2022
News Daily News Surgery for IE After TAVI No Better Than Antibiotics in High-Risk Patients Michael O'Riordan February 25, 2022
News Daily News Lower Costs for TAVI Valves Could Improve Access, Analysis Hints Yael L. Maxwell January 24, 2022
News Daily News SWEDEHEART Affirms SAVR’s Long-term Benefits in Young, Low-Risk AS L.A. McKeown November 30, 2021